On June 4, 2019 Myovant Sciences (NYSE: MYOV), a clinical-stage healthcare company focused on developing and commercializing innovative therapies for women’s health and prostate cancer, reported that Lynn Seely, M.D., President and Chief Executive Officer, will present at the following investor conferences (Press release, Myovant Sciences, JUN 4, 2019, https://investors.myovant.com/news-releases/news-release-details/myovant-sciences-present-upcoming-june-investor-conferences [SID1234536876]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Annual Roivant Pipeline Day in New York, NY on Thursday, June 6, 2019 at 3:20 p.m. ET

Goldman Sachs 40th Annual Global Healthcare Conference in Rancho Palos Verdes, CA on June 11, 2019 at 2:40 p.m. PT
A live webcast of each event will be accessible on the Events page under the Investors and Media section of the Myovant website at www.myovant.com. Please connect to the company’s website at least 15 minutes prior to the presentation to ensure adequate time for any software download that may be required to listen to the webcast. A replay of the webcast will be available at the same location for 30 days following the conference.